Skip to main content

Standard Biotools Inc 8-K, filed Nov 19, 2026

Standard Biotools Inc. (LAB)

8-K 2026-11-19 For: 2026-11-19
View Original
Added on November 19, 2026

About this 8-K

Standard Biotools Inc filed this 8-K on November 19, 2026.

Standard BioTools stockholders approved all seven proposals at a November 19, 2026 special meeting, including share issuance tied to the Merger with Treeline Biosciences. The approved charter amendment covers a reverse stock split at a ratio in the range from 1-for-20 to 1-for-40 and a name change to Treeline Biosciences, Inc. The Element Mass Cytometry divestiture was also approved, with 276,299,544 votes for. AI summary

Items reported

  • Item 5.02: Director or officer change, or executive pay
  • Item 5.07: Shareholder vote results
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits